Company signals · MedTech
HistoSonics
1 signal in the current window, with MitchelLake's leadership read on each.
Market context: the MitchelLake Talent Market Index reads 108.5 — Hot; Americas signal share is easing (-9.8pts).
Signals at HistoSonics
More signals across MedTech
Product Launch · Americas
Orchid →Vancouver-based AI startup Orchid launched a free World Cup experience allowing fans to receive live scores, match information, and local guidance through text messaging. This consumer-facing launch demonstrates the broader AI personal assistant platform capabilities for real-time experiences beyond workplace productivity.
Geographic Expansion · Oceania
Medtronic →Medtronic is expanding its Stealth AXiS product line into European markets
Partnership · EMEA
Cepheid →Cepheid launched landmark 30-month study with the Fleming Initiative at London NHS Trusts to evaluate rapid CPE screening for drug-resistant infections
Product Launch · EMEA
ZEISS Medical Technology →ZEISS successfully completed early clinical implantations of AT LUCIA toric 721P intraocular lens across six European countries. Product is CE marked and expected to launch commercially in select European markets later in 2026.
Capital Raising · EMEA
Nanordica Medical →Estonia-based Nanordica Medical raised €1.6M to bring its antibiotic-free chronic wound treatment to market and complete clinical trials ahead of European launch.
Capital Raising · Oceania
EBR Systems →EBR Systems secured underwriting for A$150 million CDI offer at A$0.38 per security